Copyright: ©Author(s) 2026.
World J Orthop. May 18, 2026; 17(5): 118163
Published online May 18, 2026. doi: 10.5312/wjo.v17.i5.118163
Published online May 18, 2026. doi: 10.5312/wjo.v17.i5.118163
Table 1 Patient demographics, n (%)/mean ± SD
| PAM + MPFLR group (n = 30) | MPFLR group | P value | PAM + MPFLR cases with type B TD (n = 14) | MPFLR cases with type B TD (n = 10) | P value | |
| Age (year) | 25.47 ± 8.27 | 24.25 ± 7.28 | 0.5961 | 25.36 ± 8.39 | 28.30 ± 7.30 | 0.3821 |
| Sex (male/female) (n) | 6/24 | 7/13 | 0.2362 | 2/12 | 5/5 | 0.0853 |
| Side (L/R) (n) | 17/13 | 9/11 | 0.4192 | 10/4 | 5/5 | 0.2852 |
| Follow-up (month) | 27.27 ± 5.19 | 27.55 ± 4.47 | 0.8431 | 27.64 ± 6.67 | 27.40 ± 4.38 | 0.9211 |
| Dejour type | 0.0003 | |||||
| Normal | 0 (0) | 0 (0) | ||||
| Type A | 0 (0) | 8 (40.0) | ||||
| Type B | 14 (46.7) | 10 (50.0) | ||||
| Type C | 3 (10.0) | 1 (5.0) | ||||
| Type D | 13 (43.3) | 1 (5.0) |
Table 2 Comparison of patient-reported outcome measure scores between the precise arthroscopic mini-trochleoplasty + medial patellofemoral ligament reconstruction and medial patellofemoral ligament reconstruction groups and subgroups with type B trochlear dysplasia
| PAM + MPFLR group (n = 30) | MPFLR group | P value1 | PAM + MPFLR cases with type B TD (n = 14) | MPFLR cases with type B TD (n = 10) | P value1 | |
| VAS score | ||||||
| Preoperative | 1.73 ± 1.48 | 5.45 ± 2.67 | 0.000 | 1.71 ± 1.27 | 5.00 ± 2.63 | 0.000 |
| Postoperative | 1.03 ± 0.85 | 0.95 ± 0.83 | 0.733 | 1.21 ± 0.89 | 0.80 ± 0.92 | 0.280 |
| P value1 | 0.029 | 0.000 | 0.238 | 0.000 | ||
| IKDC score | ||||||
| Preoperative | 58.93 ± 22.71 | 57.64 ± 16.60 | 0.829 | 56.32 ± 24.01 | 54.14 ± 7.05 | 0.784 |
| Postoperative | 77.28 ± 9.58 | 87.13 ± 6.07 | 0.000 | 77.83 ± 7.62 | 86.44 ± 5.33 | 0.006 |
| P value1 | 0.000 | 0.000 | 0.004 | 0.000 | ||
| KOOS score | ||||||
| Pain | ||||||
| Preoperative | 80.09 ± 15.56 | 65.83 ± 14.19 | 0.002 | 78.57 ± 16.43 | 64.72 ± 13.74 | 0.041 |
| Postoperative | 90.83 ± 6.93 | 92.64 ± 3.85 | 0.295 | 90.67 ± 6.94 | 93.06 ± 3.98 | 0.341 |
| P value1 | 0.001 | 0.000 | 0.017 | 0.000 | ||
| Symptoms | ||||||
| Preoperative | 68.93 ± 20.29 | 67.86 ± 19.15 | 0.852 | 72.70 ± 18.46 | 70.71 ± 15.13 | 0.782 |
| Postoperative | 87.50 ± 9.37 | 87.32 ± 7.81 | 0.944 | 89.80 ± 7.66 | 84.64 ± 8.26 | 0.130 |
| P value1 | 0.000 | 0.000 | 0.004 | 0.020 | ||
| ADL | ||||||
| Preoperative | 74.02 ± 21.90 | 67.06 ± 20.16 | 0.262 | 72.90 ± 22.53 | 68.68 ± 15.76 | 0.616 |
| Postoperative | 90.88 ± 6.69 | 92.35 ± 2.68 | 0.356 | 91.60 ± 7.15 | 91.62 ± 2.20 | 0.992 |
| P value1 | 0.000 | 0.000 | 0.006 | 0.000 | ||
| Sport/Rec | ||||||
| Preoperative | 61.33 ± 27.70 | 53.75 ± 21.51 | 0.307 | 58.57 ± 26.71 | 54.50 ± 18.17 | 0.681 |
| Postoperative | 77.33 ± 17.06 | 86.00 ± 5.28 | 0.033 | 78.57 ± 17.91 | 86.50 ± 4.74 | 0.188 |
| P value1 | 0.013 | 0.000 | 0.028 | 0.000 | ||
| QOL | ||||||
| Preoperative | 55.42 ± 21.88 | 55.94 ± 21.41 | 0.934 | 54.02 ± 24.95 | 58.13 ± 9.79 | 0.628 |
| Postoperative | 80.42 ± 8.00 | 82.50 ± 6.60 | 0.339 | 80.80 ± 5.73 | 81.25 ± 7.80 | 0.873 |
| P value1 | 0.000 | 0.000 | 0.001 | 0.000 | ||
| Lysholm score | ||||||
| Preoperative | 51.40 ± 27.49 | 48.95 ± 7.84 | 0.700 | 49.29 ± 28.71 | 48.80 ± 8.00 | 0.959 |
| Postoperative | 87.73 ± 9.46 | 89.65 ± 3.39 | 0.390 | 87.00 ± 7.76 | 88.40 ± 2.88 | 0.593 |
| P value1 | 0.000 | 0.000 | 0.000 | 0.000 | ||
| Tegner activity score | ||||||
| Preoperative | 2.87 ± 1.96 | 1.90 ± 1.25 | 0.057 | 2.71 ± 1.86 | 1.60 ± 1.07 | 0.104 |
| Postoperative | 5.03 ± 1.54 | 5.95 ± 1.10 | 0.026 | 4.93 ± 1.49 | 5.90 ± 1.20 | 0.103 |
| P value1 | 0.000 | 0.000 | 0.002 | 0.000 | ||
Table 3 Comparison of patellar instability risk factors between the two groups
| PAM + MPFLR group (n = 30) | MPFLR group (n = 20) | P value1 | |
| TT-TG distance (mm; threshold: 16.4 mm[26]) | |||
| Preoperative | 18.30 ± 2.86 | 15.47 ± 3.24 | 0.002 |
| Postoperative | 13.90 ± 2.32 | 14.59 ± 2.22 | 0.306 |
| P value1 | 0.000 | 0.324 | |
| LTI (°; threshold: 16.2°[26]) | |||
| Preoperative | -4.91 ± 11.00 | 10.52 ± 7.07 | 0.000 |
| Postoperative | 15.67 ± 9.81 | 10.98 ± 6.96 | 0.071 |
| P value1 | 0.000 | 0.839 | |
| LPT (°; threshold: 17.2°[26]) | |||
| Preoperative | 29.33 ± 9.05 | 26.05 ± 7.12 | 0.179 |
| Postoperative | 11.58 ± 8.13 | 14.13 ± 6.87 | 0.254 |
| P value1 | 0.000 | 0.000 | |
Table 4 Comparison of postoperative complications and clinical data between the precise arthroscopic mini-trochleoplasty + medial patellofemoral ligament reconstruction and medial patellofemoral ligament reconstruction groups, n (%)
| PAM + MPFLR group (n = 30) | MPFLR group | P value1 | PAM + MPFLR cases with type B TD (n = 14) | MPFLR cases with type B TD (n = 10) | P value1 | |
| Redislocation | 1 (3.3) | 0 (0) | 1.000 | 0 (0) | 0 (0) | 1.000 |
| Postoperative subluxation | 0 (0) | 0 (0) | 1.000 | 0 (0) | 0 (0) | 1.000 |
| Apprehension sign | 2 (6.7) | 5 (25.0) | 0.100 | 1 (7.1) | 4 (40.0) | 0.075 |
| Residual instability | 3 (10.0) | 5 (25.0) | 0.240 | 1 (7.1) | 4 (40.0) | 0.075 |
| Reduced range of motion | 1 (3.3) | 0 (0) | 1.000 | 1 (7.1) | 0 (0) | 1.000 |
| Reoperation | 1 (3.3) | 0 (0) | 1.000 | 1 (7.1) | 0 (0) | 1.000 |
| Increased pain | 2 (6.7) | 1 (5.0) | 1.000 | 0 (0) | 0 (0) | 1.000 |
| Stiffness | 0 (0) | 0 (0) | 1.000 | 0 (0) | 0 (0) | 1.000 |
| Infection | 0 (0) | 0 (0) | 1.000 | 0 (0) | 0 (0) | 1.000 |
| Deep vein thrombosis | 1 (3.3) | 0 (0) | 1.000 | 0 (0) | 0 (0) | 1.000 |
- Citation: Xu H, Ding M, Liao BH, Lei SG, Zheng C, Wang YC. Precise arthroscopic mini-trochleoplasty combined with medial patellofemoral ligament reconstruction yields comparable complications to isolated medial patellofemoral ligament reconstruction. World J Orthop 2026; 17(5): 118163
- URL: https://www.wjgnet.com/2218-5836/full/v17/i5/118163.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i5.118163